High-Resolution Preclinical Multimodal PET/SPECT/CT Nuclear Imaging System
High-Resolution Preclinical Multimodal PET/SPECT/CT Nuclear Imaging System
批准号:
MR/X012395/1
负责人:
Tammy Kalber
金额:
$81.5万
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2022
资助国家:
英国
项目状态:
已结题
起止时间:
2022 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Nuclear imaging is a branch of medical imaging that uses small amounts of radioactive material to diagnose and treat a variety of diseases. The emphasis of nuclear imaging is not anatomical but based on function. Radioactive tracers are designed to be actively taken up by a specific cell process to provide information of the physiological pathology of a disease. For example radioactive glucose is a sugar taken up by highly replicating cancer cells compared to normal cells allowing us to distinguish between benign and tumorous lesions. Nuclear imaging is broken down into two imaging disciplines; Single photon emission computed tomography (SPECT) and positron emission tomography (PET), each have their own advantages for radioactive tracer development for identifying specific disease physiology. These three-dimensional imaging techniques are combined with computerized tomography (CT), a procedure that uses special x-ray equipment to create detailed pictures of the areas inside the body, for localization. In this application we request a highly sensitive multimodal PET/SPECT/CT system into which live mice can be placed. This equipment will allow us to follow radioactively labelled drugs, molecules, and cells to provide invaluable data on the function of organs in disease states and find new treatments for incurable diseases such as cardiovascular disease, neurological disorders and cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Generation of Multi-Modal Imaging Mesenchymal Stem Cells
-
批准号:EP/L006472/1
-
项目类别:Fellowship
-
资助金额:$118.95万
-
财政年份:2014
-
负责人:Tammy Kalber
-
依托单位:
海外基金